Belleville, NJ, United States of America

Ryan Murelli

USPTO Granted Patents = 12 (Patent Applications = 3)

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 3.3

ph-index = 5

Forward Citations = 121(Granted Patents)

Location History:

Torrington, CT (US) (2014)
Belleville, NJ (US) (2016 - 2024)

Company Filing History:

Saint Louis University

patents

4 out of 328

The City University of New York

patents

4. 1 out of 894

The United States Government As Represented by the Department of Veterans Affairs

patents

where one patent can have more than one assignee

Years Active: 2014-2025

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12502362 - Inhibitors of nucleotidyltransferase superfamily enzymes as antibiotics (2025-12-23),

2. 12121500 - Inhibitors of Bunyaviridae and uses thereof (2024-10-22),

3. 12084517 - Chimeric small molecules for the recruitment of antibodies to cancer cells (2024-09-10),

4. 11725064 - Chimeric small molecules for the recruitment of antibodies to cancer cells (2023-08-15),

5. 11420922 - Hydroxylated tropolone inhibitors of nucleotidyl transferases in herpesvirus and Hepatitis B and uses therefor (2022-08-23),

6. 11014992 - Chimeric small molecules for the recruitment of antibodies to cancer cells (2021-05-25),

7. 10980754 - Anti-fungal compounds (2021-04-20),

8. 10703823 - Chimeric small molecules for the recruitment of antibodies to cancer cells (2020-07-07),

9. 10066026 - Chimeric small molecules for the recruitment of antibodies to cancer cells (2018-09-04),

10. 9296708 - Chimeric small molecules for the recruitment of antibodies to cancer cells (2016-03-29),

11. 8859509 - Chimeric small molecules for the recruitment of antibodies to cancer cells (2014-10-14),

12. 8852630 - Chimeric small molecules for the recruitment of antibodies to cancer cells (2014-10-07),

Title: The Innovative Mind of Ryan Murelli

Introduction

Ryan Murelli, based in Belleville, NJ, is a distinguished inventor with a portfolio of 11 patents. His work primarily focuses on biochemistry and its applications in medical science, particularly in the fight against viral infections and cancer.

Latest Patents

Amongst his latest inventions is a patent titled "Inhibitors of Bunyaviridae and uses thereof." This patent presents various inhibitors effective against bunyaviruses, including those responsible for infections such as Rift Valley phlebovirus, hantavirus, La Crosse virus, and Crimean-Congo Hemorrhagic fever. Another noteworthy patent is "Chimeric small molecules for the recruitment of antibodies to cancer cells." This innovative chemical compound aims to enhance the targeting of antibodies specifically to prostate cancer cells, enhancing the potential for more effective treatments.

Career Highlights

Ryan has made significant contributions to research during his tenure at prominent institutions such as Yale University and Saint Louis University. His background in these reputable universities highlights his commitment to advancing scientific knowledge and innovation.

Collaborations

Throughout his career, Ryan has collaborated with esteemed professionals in the field, including David Spiegel and Andrew Zhang. These collaborations have fostered a rich environment for idea exchange and fueled further innovations, amplifying the impact of his inventions.

Conclusion

Ryan Murelli stands out as a remarkable inventor whose work continues to influence various sectors, especially in combating viral diseases and cancer. His dedication to innovation and collaboration showcases the essence of modern scientific research and the relentless pursuit of solutions to pressing health challenges.

This text is generated by artificial intelligence and may not be accurate.